NCT00416819 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Primary CNS Lymphoma Status COMPLETED Phase NA
NCT00416598 Decitabine as Maintenance Therapy After Standard Therapy in Treating Patients With Previously Untreated Acute Myeloid Leukemia Status COMPLETED Phase PHASE2
NCT00410696 Pegfilgrastim Versus Filgrastim After High-dose Chemotherapy Status COMPLETED Phase PHASE2
NCT00410631 Observation, Combination Chemotherapy, Radiation Therapy, and/or Autologous Stem Cell Transplant in Treating Young Patients With Neuroblastoma Status UNKNOWN Phase PHASE3
NCT00407888 Doxorubicin Hydrochloride, Cyclophosphamide, and Filgrastim Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation With or Without Trastuzumab in Treating Patients With Breast Cancer Previously Treated With Surgery Status COMPLETED Phase PHASE2
NCT00404066 Phase 2 Neoadjuvant Doxorubicin and Cyclophosphamide -> Docetaxel With Lapatinib in Stage II/III Her2Neu+ Breast Cancer Status COMPLETED Phase PHASE2
NCT00393029 Phase II Study of Metastatic Cancer That Overexpresses P53 Using Lymphodepleting Conditioning Followed by Infusion of Anti-P53 TCR-Gene Engineered Lymphocytes Status COMPLETED Phase PHASE2
NCT00392834 Rituximab and Combination Chemotherapy in Treating Patients With Newly Diagnosed, HIV-Associated Burkitt's Lymphoma Status COMPLETED Phase PHASE2
NCT00392340 Topotecan, Vincristine, and Doxorubicin in Treating Young Patients With Refractory Stage 4 Neuroblastoma Status UNKNOWN Phase PHASE2
NCT00392327 Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed, Previously Untreated, High-Risk Medulloblastoma/PNET Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00389818 Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed AIDS-Related B-Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00387959 Chemotherapy, Radiation Therapy, Rituximab, and Umbilical Cord Blood Transplant in Treating Patients With B-Cell Non-Hodgkin's Lymphoma Status COMPLETED Phase PHASE2
NCT00381940 Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy Status COMPLETED Phase PHASE2
NCT00381680 Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia Status COMPLETED Phase PHASE3
NCT00357565 Hematopoietic Stem Cell Transplantation in the Treatment of Infant Leukemia Status COMPLETED Phase PHASE2
NCT00354744 High-Dose Combination Chemotherapy and Radiation Therapy in Treating Patients With Newly Diagnosed Metastatic Rhabdomyosarcoma or Ectomesenchymoma Status COMPLETED Phase PHASE3
NCT00354419 Cyclophosphamide, Antithymocyte Globulin, and Total-Body Irradiation in Treating Patients With Severe Aplastic Anemia Undergoing Umbilical Cord Blood Transplant Status TERMINATED Phase PHASE1
NCT00354172 Donor Umbilical Cord Blood Natural Killer Cells, Aldesleukin and Umbilical Cord Blood Transplant in Patients With Refractory Hematologic Cancers. Status TERMINATED Phase PHASE2
NCT00352118 Combination Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Head and Neck Cancer Status TERMINATED Phase PHASE2
NCT00349778 High-Dose Sequential Therapy and Single Autologous Transplantation for Multiple Myeloma Status COMPLETED Phase PHASE2